
Jan 8 (Reuters) - Trevi Therapeutics Inc TRVI.O:
TREVI THERAPEUTICS PROVIDES STRATEGIC UPDATES AHEAD OF ANNUAL LIFESCI PARTNERS CORPORATE ACCESS EVENT HELD DURING THE J.P. MORGAN HEALTHCARE CONFERENCE
TREVI THERAPEUTICS INC - FDA END-OF-PHASE 2 MEETING SCHEDULED FOR Q1 2026
TREVI THERAPEUTICS INC - PHASE 2B REFRACTORY CHRONIC COUGH TRIAL TO START IN H1 2026